Sangamo BioSciences | SGMO - Current Assets

Stock Price
0.35
Daily Change
0 0%
Monthly
-20.11%
Yearly
-58.40%
Q1 Forecast
0.32

Sangamo BioSciences reported $49.89M in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Alnylam Pharmaceuticals USD 4.05B 97.85M Dec/2025
Alterity Therapeutics Limited AUD 27.05M 6.16M Jun/2023
Amgen USD 29.06B 1.17B Dec/2025
Bayer EUR 32.91B 30M Dec/2025
BioCryst Pharmaceuticals USD 404.35M 48.66M Dec/2025
Biogen USD 8.97B 37.5M Dec/2025
BioMarin Pharmaceutical USD 3.95B 98.95M Dec/2025
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Grifols EUR 5.96B 316.31M Dec/2025
Ionis Pharmaceuticals USD 2.99B 471.01M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Karyopharm Therapeutics USD 89.75M 8.12M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 30.46B 2.26B Dec/2025
Omeros USD 69.65M 26.53M Jun/2025
Pfizer USD 46.92B 3.22B Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Sarepta Therapeutics USD 2.54B 184.37M Dec/2025
Tectonic Therapeutic USD 257.36M 15.88M Dec/2025
Ultragenyx Pharmaceutical USD 643.21M 76.58M Sep/2025
Vertex Pharmaceuticals USD 11.2B 631.4M Dec/2025